Skip to content
Governance Register

← US public companies

Emmaus Life Sciences, INC.

SEC CIK 1420031 · [NONE] · last insider filing 2019-07-12

Directors (from insider filings)

NameCapacity as filedFilings
ZEN Wei Peu Director filed 2018 - 2019
Niihara Yutaka Director · President and CEO filed 2011 - 2019
Dickey Robert IV Director filed 2018 - 2018
Zwicker Ian Harvey Director filed 2015 - 2018
Osato Masaharu Director filed 2016 - 2018
Kuwahara Jon Director filed 2016 - 2018
LEE Willis C Director · Vice Chairman & COO filed 2011 - 2016
Sris Mayu Director filed 2014 - 2014
Satow Phillip M Director filed 2014 - 2014
Kurisu Duane K Director filed 2014 - 2014
Miyashita Akiko Moni Director filed 2014 - 2014
Dewald Maurice J Director filed 2011 - 2014
Mckinnell Henry A Director filed 2011 - 2014
Doi Tracey Director filed 2011 - 2014
Osborne Alfred E JR Director filed 2011 - 2012
Heshmatpour Amir F Director · President, Secretary filed 2008 - 2012
Griffin Ventures Ltd. Director filed 2011 - 2012
Warnecke Steve B Director filed 2011 - 2011
Wilmore Douglas Director filed 2011 - 2011
AFH Holding & Advisory, LLC Director filed 2008 - 2011
Brasel Timothy Director · Vice President filed 2010 - 2011

Officers (from insider filings)

NameTitle as filedFilings
Sherwood Joseph Charles III Chief Financial Officer filed 2019 - 2019
Kruger Kurt H Chief Financial Officer filed 2018 - 2018
Tran Lan T. Chief Administrative Officer filed 2011 - 2016
Nagasaki Yasushi Senior Vice President, Finance filed 2011 - 2016
Ludlum Peter Exe Vice Pres. & CFO filed 2012 - 2016
Lee Sangho Steve Interim-CFO filed 2016 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.